Avid Bioservices Inc (NAS:CDMO)
$ 9.12 -0.08 (-0.87%) Market Cap: 578.94 Mil Enterprise Value: 743.13 Mil PE Ratio: 0 PB Ratio: 3.21 GF Score: 72/100

Q2 2021 Avid Bioservices Inc Earnings Call Transcript

Dec 02, 2020 / 09:30PM GMT
Release Date Price: $9.5 (+8.20%)
Operator

Good day, ladies and gentlemen, and welcome to the Avid Bioservices Second Quarter Fiscal 2021 Financial Results Conference Call. (Operator Instructions) As a reminder, this conference call may be recorded.

I would now like to hand the conference over to Tim Brons of Avid's Investor Relations Group. Please go ahead.

Tim Brons
Vida Strategic Partners Inc. - EVP

Thank you. Good afternoon, and thank you for joining us. On today's call, we have Nick Green, President and CEO; Dan Hart, Chief Financial Officer; and Timothy Compton, Chief Commercial Officer.

Today, we will be putting an overview of Avid Bioservices contract development and manufacturing business, including updates on corporate activities and financial results for the quarter ended October 31, 2020. After our prepared remarks, we will welcome your questions.

Before we begin, I'd like to caution that comments made during this conference call today, December 2, 2020, will contain certain forward-looking statements within the meaning of the Private Securities Litigation

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot